WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005111006) RITONAVIR ANALOGOUS COMPOUND USEFUL AS RETROVIRAL PROTEASE INHIBITOR, PREPARATION OF THE RITONAVIR ANALOGOUS COMPOUND AND PHARMACEUTICAL COMPOSITION FOR THE RITONAVIR ANALOGOUS COMPOUND.
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/111006    International Application No.:    PCT/BR2005/000077
Publication Date: 24.11.2005 International Filing Date: 11.05.2005
IPC:
C07D 277/24 (2006.01), C07D 277/28 (2006.01)
Applicants: CRISTÁLIA PRODUTOS QUÍMICOS FARMACÊUTICOS LTDA. [BR/BR]; AV. PAOLETTI, 363, 13974-970 ITAPIRA (BR) (For All Designated States Except US).
BOCKELMANN, Maria Alice [BR/BR]; (BR) (For US Only).
ROSATTO, Simone Soares [BR/BR]; (BR) (For US Only).
FUZETO, Cláudio Roberto [BR/BR]; (BR) (For US Only).
VERNUCCI, Thiago Boscaro [BR/BR]; (BR) (For US Only).
BAREL, Daniela Cecília [BR/BR]; (BR) (For US Only).
OLIVEIRA, Kesley Moraes Godinho de [BR/BR]; (BR) (For US Only).
FREITAS, Matheus Puggina de [BR/BR]; (BR) (For US Only)
Inventors: BOCKELMANN, Maria Alice; (BR).
ROSATTO, Simone Soares; (BR).
FUZETO, Cláudio Roberto; (BR).
VERNUCCI, Thiago Boscaro; (BR).
BAREL, Daniela Cecília; (BR).
OLIVEIRA, Kesley Moraes Godinho de; (BR).
FREITAS, Matheus Puggina de; (BR)
Agent: LLC INFO CONNECTION LTDA.; AV. DOM HÉLDER CÂMARA, 5555 SALA 312 - PILARES, 20771-001 RIO DE JANEIRO (BR)
Priority Data:
PI0401742-0 13.05.2004 BR
Title (EN) RITONAVIR ANALOGOUS COMPOUND USEFUL AS RETROVIRAL PROTEASE INHIBITOR, PREPARATION OF THE RITONAVIR ANALOGOUS COMPOUND AND PHARMACEUTICAL COMPOSITION FOR THE RITONAVIR ANALOGOUS COMPOUND.
(FR) COMPOSE ANALOGUE DU RITONAVIR UTILE COMME INHIBITEUR DE PROTEASE RETROVIRAL, PROCEDE DE PREPARATION DE CE COMPOSE ET COMPOSITION PHARMACEUTIQUE CORRESPONDANTE
Abstract: front page image
(EN)The present invention describes a new one ritonavir analogous compound that presents significantly superior activity in inhibition of HIV protease. There are also described the usage of the ritonavir analogous compound of the present invention or salt, ester or prodrug thereof as well as the usage of the compound and its pharmaceutical compositions in medicine, particularly, in the treatment of HIV infection, by itself or in combination with others anti-HIV drugs.
(FR)L'invention concerne un nouveau composé analogue du ritonavir qui présente une activité considérablement supérieure d'inhibition de la protéase du VIH. L'invention concerne aussi l'utilisation du composé analogue du ritonavir ou d'un sel, d'un ester ou d'un promédicament de celui-ci ainsi que l'utilisation médicale du composé et de ses compositions pharmaceutiques, seul(s) ou combiné(s) à d'autres médicaments anti-VIH, pour traiter notamment une infection par le VIH.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)